波西米亚
Lv65
2800 积分
2024-05-06 加入
-
3D time-series phenotyping of lettuce in greenhouses
9天前
已完结
-
Old drug, new use: Recent advances for G-CSF
27天前
已完结
-
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
30天前
已完结
-
A backbone-centred energy function of neural networks for protein design
1个月前
已完结
-
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2个月前
已完结
-
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
2个月前
已完结
-
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
2个月前
已完结
-
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial
2个月前
已完结
-
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2个月前
已完结
-
Characterization of the dual ITK/JAK3 small molecule covalent inhibitor ATI-2138
2个月前
已完结